Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer

Abstract Ovarian cancer is a highly aggressive disease and novel treatments are required. Thyroid hormones binding to αvβ3 integrin produced growth-promoting activities in ovarian cancer and we hypothesized that natural thyroid hormone derivatives may antagonize these actions. The effect of three an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elena Shinderman-Maman, Keren Cohen, Dotan Moskovich, Aleck Hercbergs, Haim Werner, Paul J. Davis, Martin Ellis, Osnat Ashur-Fabian
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0387e756b4e9437087dee0edd92fdf52
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0387e756b4e9437087dee0edd92fdf52
record_format dspace
spelling oai:doaj.org-article:0387e756b4e9437087dee0edd92fdf522021-12-02T15:05:44ZThyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer10.1038/s41598-017-16593-x2045-2322https://doaj.org/article/0387e756b4e9437087dee0edd92fdf522017-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-16593-xhttps://doaj.org/toc/2045-2322Abstract Ovarian cancer is a highly aggressive disease and novel treatments are required. Thyroid hormones binding to αvβ3 integrin produced growth-promoting activities in ovarian cancer and we hypothesized that natural thyroid hormone derivatives may antagonize these actions. The effect of three antagonists, tetraiodoacetic acid (tetrac), triiodothyroacetic acid (triac) and 3-iodothyronamine (T1AM), on cell proliferation, cell death and DNA damage was studied in two ovarian cancer cell lines (OVCAR3 and A2780), normal hamster ovary control cells (CHOK1) and αvβ3-deficient or transfected HEK293 cells. A differential inhibition of cell proliferation was observed in ovarian cancer cells compared to CHOK1. In OVCAR3, an induction of cell cycle regulators was further shown. Apoptosis was confirmed (annexin-PI, SubG1/cell-cycle, apoptotic genes, caspase-3 and poly ADP ribose polymerase-1 (PARP-1) cleavage) and was reversed by a pan-caspase inhibitor. Induction in apoptosis inducing factor (AIF) was observed, suggesting a parallel caspase-independent mechanism. Integrin-involvement in triac/T1AM apoptotic action was shown in αvβ3-transfected HEK293 cells. Lastly, in ovarian cancer models, key proteins that coordinate recognition of DNA damage, ataxia-telangiectasia mutated (ATM) and PARP-1, were induced. To conclude, the cytotoxic potential of thyroid hormone derivatives, tetrac, triac and T1AM, in ovarian cancer may provide a much-needed novel therapeutic approach.Elena Shinderman-MamanKeren CohenDotan MoskovichAleck HercbergsHaim WernerPaul J. DavisMartin EllisOsnat Ashur-FabianNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Elena Shinderman-Maman
Keren Cohen
Dotan Moskovich
Aleck Hercbergs
Haim Werner
Paul J. Davis
Martin Ellis
Osnat Ashur-Fabian
Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
description Abstract Ovarian cancer is a highly aggressive disease and novel treatments are required. Thyroid hormones binding to αvβ3 integrin produced growth-promoting activities in ovarian cancer and we hypothesized that natural thyroid hormone derivatives may antagonize these actions. The effect of three antagonists, tetraiodoacetic acid (tetrac), triiodothyroacetic acid (triac) and 3-iodothyronamine (T1AM), on cell proliferation, cell death and DNA damage was studied in two ovarian cancer cell lines (OVCAR3 and A2780), normal hamster ovary control cells (CHOK1) and αvβ3-deficient or transfected HEK293 cells. A differential inhibition of cell proliferation was observed in ovarian cancer cells compared to CHOK1. In OVCAR3, an induction of cell cycle regulators was further shown. Apoptosis was confirmed (annexin-PI, SubG1/cell-cycle, apoptotic genes, caspase-3 and poly ADP ribose polymerase-1 (PARP-1) cleavage) and was reversed by a pan-caspase inhibitor. Induction in apoptosis inducing factor (AIF) was observed, suggesting a parallel caspase-independent mechanism. Integrin-involvement in triac/T1AM apoptotic action was shown in αvβ3-transfected HEK293 cells. Lastly, in ovarian cancer models, key proteins that coordinate recognition of DNA damage, ataxia-telangiectasia mutated (ATM) and PARP-1, were induced. To conclude, the cytotoxic potential of thyroid hormone derivatives, tetrac, triac and T1AM, in ovarian cancer may provide a much-needed novel therapeutic approach.
format article
author Elena Shinderman-Maman
Keren Cohen
Dotan Moskovich
Aleck Hercbergs
Haim Werner
Paul J. Davis
Martin Ellis
Osnat Ashur-Fabian
author_facet Elena Shinderman-Maman
Keren Cohen
Dotan Moskovich
Aleck Hercbergs
Haim Werner
Paul J. Davis
Martin Ellis
Osnat Ashur-Fabian
author_sort Elena Shinderman-Maman
title Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
title_short Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
title_full Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
title_fullStr Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
title_full_unstemmed Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
title_sort thyroid hormones derivatives reduce proliferation and induce cell death and dna damage in ovarian cancer
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/0387e756b4e9437087dee0edd92fdf52
work_keys_str_mv AT elenashindermanmaman thyroidhormonesderivativesreduceproliferationandinducecelldeathanddnadamageinovariancancer
AT kerencohen thyroidhormonesderivativesreduceproliferationandinducecelldeathanddnadamageinovariancancer
AT dotanmoskovich thyroidhormonesderivativesreduceproliferationandinducecelldeathanddnadamageinovariancancer
AT aleckhercbergs thyroidhormonesderivativesreduceproliferationandinducecelldeathanddnadamageinovariancancer
AT haimwerner thyroidhormonesderivativesreduceproliferationandinducecelldeathanddnadamageinovariancancer
AT pauljdavis thyroidhormonesderivativesreduceproliferationandinducecelldeathanddnadamageinovariancancer
AT martinellis thyroidhormonesderivativesreduceproliferationandinducecelldeathanddnadamageinovariancancer
AT osnatashurfabian thyroidhormonesderivativesreduceproliferationandinducecelldeathanddnadamageinovariancancer
_version_ 1718388684613484544